Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models

Author: Chang Yong   Adnane Jalila   Trail Pamela   Levy Joan   Henderson Arris   Xue Dahai   Bortolon Elizabeth   Ichetovkin Marina   Chen Charles   McNabola Angela   Wilkie Dean   Carter Christopher   Taylor Ian   Lynch Mark   Wilhelm Scott  

Publisher: Springer Publishing Company

ISSN: 0344-5704

Source: Cancer Chemotherapy and Pharmacology, Vol.59, Iss.5, 2007-04, pp. : 561-574

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content